Source Feed: Global News - Canada
Author: Adriana Fallico
Publication Date: April 2, 2026 - 14:38
Stay informed
Unpublished Opinions
Common antidepressant may help adults with long COVID: study
April 2, 2026
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Unpublished Newswire
April 21, 2026 - 22:18 | Matthew Scace | The Globe and Mail
April 21, 2026 - 22:00 | Mike Hager | The Globe and Mail
April 21, 2026 - 21:59 | Josh O’Kane | The Globe and Mail
Comments
Be the first to comment